Product Details
Product Name:
SBP-3264 |
Purity:
99.46% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | SBP-3264 |
Description | SBP-3264 is a novel inhibitor of serine/threonine-protein kinases 3 and 4 (STK3 and STK4). |
In vitro | SBP-3264 specifically inhibited the Hippo signaling pathway in cultured mammalian cells. |
In vivo | SBP-3264 possessed favorable pharmacokinetic and pharmacodynamic properties in mice. |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 1 mg/ml, Sonication is recommended.
|
Keywords | SBP3264 | SBP-3264 | SBP 3264 |
Related Compound Libraries | Bioactive Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:77518-23-1
$293.00 / 1mg
-
CAS:1884222-74-5
$59.00 / 1mg
-
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$80.00/1KG |
|
Hebei Ruiyao Biotechnology Co. Ltd
|
2021-04-02 |